PRPO
Precipio, Inc. NASDAQ Listed Jun 30, 2017$24.64
+4.05%
vs $23.68
Mkt Cap $44.0M
52w Low $13.02
56.4% of range
52w High $33.63
50d MA $24.56
200d MA $24.18
P/E (TTM)
-50.9x
EV/EBITDA
39.0x
P/B
2.7x
Debt/Equity
0.2x
ROE
-2.5%
P/FCF
110.2x
RSI (14)
55.80
ATR (14)
$2.29
Beta
1.20
50d MA
$24.56
200d MA
$24.18
Avg Volume
55.6K
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
4 Science Park · New Haven, CT 06511 · US
Data updated apr 26, 2026 8:49pm
· Source: financialmodelingprep.com